Erlotinib is the inhibitor of epidermal growth factor receptor (EGFR), which is highly over-expressed in many types of solid tumors, e.g., breast, ovarian, lung, colorectal, or head and neck cancers. The gene discussed is EGFR; the disease is head and neck cancer.